Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Accenture
Johnson and Johnson
Fuji
McKesson
Colorcon

Generated: April 19, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: atazanavir sulfate; ritonavir

« Back to Dashboard

atazanavir sulfate; ritonavir Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Matrix Labs Ltd atazanavir sulfate; ritonavir 022282 300MG/100MG TABLET; ORAL
Emcure Pharms Ltd atazanavir sulfate; ritonavir 205508 300MG; 100MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Citi
Covington
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.